Endothelial cell apoptosis plays an important role in the pathophysiological mechanism of vascular complications in type 2 diabetes mellitus (T2DM). Argirein, a new synthetic compound was demonstrated to inactivate NADPH oxidase to alleviate cardiac dysfunction in T2DM. Here, we investigated whether argirein medication attenuated the vascular dysfunction in T2DM by inhibiting endothelial cell apoptosis which was associated with NADPH oxidase. The rat aortic endothelial cells (RAECs) were incubated with glucose (30 mM) for 48 hour in vitro. It was shown that high glucose significantly increased the protein expression of BAX (Bcl-2 Associated X protein) and Caspase-3 and decreased Bcl2 (B-Cell Leukemia/Lymphoma 2) protein level in RAECs, which was normalized by argirein medication. The annexin V-FITC bound cell percentage and DNA fragments in agarose electrophoresis were markedly suppressed by argirein to confirm the anti-apoptotic property of argirein in RAECs. Furthermore, we found that argirein blocked the endothelin (ET)-1/Nox4 signal-dependent superoxide (O 2 −. ) generation, which regulated endothelial cell apoptosis in RAECs. In vivo, argirein intervention relieved the vasodilatory response to acetylcholine and restored the expressions of Nox4 and BAX in the aorta endothelium of high-fat diet (HFD)-fed rats following streptozocin (STZ) injection. For the first time, we demonstrated that argirein could inhibit vascular endothelial cell apoptosis, which was attributed to blocking ET-1/Nox4 signal-dependent O 2 − generation in RAECs. This current study revealed the therapeutic effects of argirein to prevent the vascular complication in T2DM through inhibiting endothelial cell apoptosis which was associated with the anti-oxidative property of argirein.
Western blotting analysis. The protein expression of BAX, Bcl-2, Caspase-3, Nox4, and ET A R were analyzed by western blot which was performed as we described previously 16 . In brief, RAECs were washed twice with phosphate-buffered saline (PBS) and scraped in radio immunoprecipitation assay (RIPA) lysis buffer (BU Technology CO, LTD) for 15 min at 4 °C. Cell lysate was centrifuged at 10,000 rpm/min at 4 °C for 10 min, and the supernatant was collected and determined by BCA protein quantitative kit (BU). After boiling for 5 min at 95 °C in a 5 × loading buffer (BU Technology CO, LTD), 30 μg protein was separated by 10% SDS-PAGE at 80 V for 30 min and 120 V for 1 h. Then protein was electrophoretically blotted to polyvinylidene fluoride membranes (PVDF membrane, 0.45 μm, Millipore Co. Ltd.) at 200 mA for 1 h. The membranes were blocked with 5% non-fat milk (5% w/v) in Tris-buffered saline with Tween 20 for 1.5 h. After washing three times with TBST, the membranes were probed with primary antibodies of BAX (1:500, Proteintech), Bcl-2(1:1000, CST), Caspase-3(1:500, Wanleibio), Nox4 (1:1000, Abways), and ET A R (1:1000, Sigma) overnight at 4 °C. β-actin(1:5000, Abways) or β-tubulin(1:5000, Abways) were used as control protein. After three times of wash with TBST, the membranes were incubated with the goat anti-Rabbit IgG(1:5000, Abways) as secondary antibody at room temperature for 1.5 h. The blot was detected by chemiluminescent detection systems with Super ECL Plus Detection Reagent (1:1, BU). Densitometric analysis of the images was performed with ImageJ software (NIH, Littleton, CO, USA). Apoptosis Detection Kit (Vazyme Biotech) according to the manufacturer's instructions. RAECs (1 × 10 5 cells/ well) were trypsinized and centrifugated at 1000r/min for 5 min at 4 °C. The cells were washed twice in cold (4 °C) PBS and then subjected to another centrifugation, and then the cells were resuspended in 100 µL Binding Buffer (5 × 10 5 cells/100 µL). After the incubation with 5 µL Annexin V-FITC and 5 µL propidium Iodide (PI) staining solution for 10 min without light, the cells were detected by a flow cytometer (MACSQuant) within 1 hour. The data was analyzed by FlowJo 7.6 software, and the percentage of cells to total cells was calculated as the rate of apoptotic cells.
DNA ladder assay. Fragmented DNA was a biochemical hallmark of apoptosis characterized by ladder DNA which was extracted by using the apoptotic DNA ladder kit (Nanjing Angle Gene Biotechnology co. LTD). DNA extraction from RAECs was conducted according to the manufacturer's instructions. DNA extraction was treated with RNase for 15 min at room temperature and proteinase K. DNA samples were applied to a 1% agarose gel electrophoresis at 60 V for 3.5 h.
TUNEL assay.
A high sensitive one-step Terminal deoxyribonucleotide transferase dUTP nick end labelling (TUNEL) apoptosis assay kit (Beyotime Institute of Biotechnology, Jiangsu, China) was used to label DNA strand break according to the manufacturer's instruction. TUNEL reagent was performed on RAECs and rat thoracic aortas to detect apoptosis. RAECs were fixed with 4% paraformaldehyde for 30 min. And after washing with PBS, they were permeabilized by 0.3% Triton X-100. For tissue slides, paraffin sections were firstly dewaxed with dimethylbenzene and rehydrated with ethanol solution (gradient concentration) and distilled water. Then cells and slides share the same step. Sections were immersed in 50 μl TUNEL reaction fluid in a humid environment at 37 °C for 1 h. After washing twice, sections were incubated with 4′, 6-diamidino-2-phenylindole (DAPI) to stain nuclei. Finally, samples were observed under fluorescence microscope.
Measurement of O 2
− production. Total O 2 −. generation by RAECs was measured using DHE (Sigma, CAS 104821-25-2). DHE was oxidized by intracellular O 2 −. and then incorporated into the chromosomal DNA in the nucleus to produce red fluorescence. After treatment, RAECs (1 × 10 4 cells/well) in 6-well plates was washed twice with PBS. Then cells were incubated with 10 μM DHE diluted in 2 ml serum free-RPMI 1640 without light at 37 °C. After 30 min incubation, RAECs were washed three times with 1-2 mL PBS, red fluorescent images were observed by fluorescence microscopy. The fluorescence intensity was analyzed by ImageJ software and the ratio of fluorescent intensity to that at basal level was quantified to represent cellular O 2 −. level. spin trap, 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH; ENZO, Alexis Corporation), and substrate NADPH (20 μM, Beyotime Biotechnology) in the presence or absence of manganese-dependent superoxide dismutase (SOD, 8000U/ml; Beyotime Biotechnology). The mixture was loaded into glass capillaries and immediately analyzed for O 2 −. production kinetically for 10 min using an ESR spectrometer (Germany BRUKER) as we previously described 17 . The SOD-inhibitable fraction of the signal in the homogenates reflected the total O 2 −. level, and the results were expressed as fold changes relative to control.
RNA interference of
Establishing of type 2 diabetic rat model. Adult SD rats were developed as a rat model of T2DM according to the method in our previous study 18 . Rats were fed with a HFD (22 g/d) consisting of 10% saccharose, 10% lard, 10% sugar, 5% egg yolk powder, 0.5% cholesterol, 74.5% basal chow. The ordinary chow was constituted by 36% corn, 23% triturate wheat, 10% bran, 12% soy bean powder, 3% egg; 12% fish powder, 2% driedyeast, 1% of amixture of calcium bicarbonate, multi-vitamins and micro-elements. Both the normal chow and high-fat diet were purchased from Qinglongshan Lab Animal Ltd (Nanjing, China).
Rats were divided into three groups (n = 8): control, untreated diabetes, and diabetes treated with argirein(200 mg/kg, i.g.). In the first 6 weeks, rats in untreated and treated diabetes group were given a HFD alone and rats in the control group only received regular chow. On the beginning of 7th week, rats fed with a HFD received a single time intraperitoneal injection of STZ (40 mg/kg, dissolved in pH 4.5 citrate buffer). Control rats only received an equivalent volume of citrate buffer. After the injection of STZ, all groups maintained their original diets. Rats on HFD with low STZ were recognized as diabetic while the FBG level reached 16.7 mM after 1 week of STZ injection. The intervention with argirein (200 mg/kg/day, i.g.) was conducted once a day for last 3 weeks. However, rats in the groups of normal and untreated diabetes were given an equal volume of saline solution. A gain of body weight was monitored at an interval of 3 days.
Blood samples from the rats were collected and centrifuged at 3000 g for 10 min at 4 °C.The serum was collected and stored at −20 °C before use. FBG and fasting insulin (FIN) were assayed following instructions of the kits provided by the Nanjing Jiancheng Bio engineering Institute (China).
Immunohistochemistry. The aortic rings were dissected and perfused with PBS and fixed in 4% paraformaldehyde (PFA) and embedded in paraffin. The paraffin sections of the aortic rings were sliced, dewaxed and washed with PBS three times for 5 min, followed by blocked with 3% H 2 O 2 for 10 min and 5% BSA for 1 hour at room temperature. For immunohistochemical studies, the sections were incubated with anti-Nox4 (1:100, Abways, China) and anti-BAX (1:50, Proteintech) at 4 °C overnight. After washing three times with PBS for 5 min, the sections were incubated with the rabbit anti-goat biotinylated secondary antibody (dilution 1:100, Abways) for 2 hours at room temperature. Diaminobenzidine (DAB) chromogen kit (Beyotime Biotechnology co, LTD.) was used for staining. The sections were counterstained with hematoxylin before examination under OLYMPUS CX31 microscope.
Vascular tension recording of rat thoracic aorta. Rats were anaesthetized by 3% chloral hydrate, then thoracic aorta was quickly removed and immersed into ice-cold Krebs Henseleit solution (mM) (KH, pH 7.4, 119.0 NaCl, 25.0 NaHCO 3 , 11.1 Glucose, 2.4 CaCl 2 , 4.7 KCl, 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 0.024 Na 2 EDTA) solution. The aortas were subtracted from free of connective tissue and fat, and then cut into three separated thoracic aortic rings with a width of approximately 2 mm. All anatomical procedures were carefully done in order to protect the endothelium from accidental damage. Aortic rings were then suspended in water-jacketed tissue baths and tested for isometric force recorded by a PowerLab system. The KH solution maintained at 37 °C and the mixed gas contained 95% O 2 and 5% CO 2 was continuously bubbled through the bath. The baseline tension placed on the aortic rings was adjusted to 2 g. The isometric tensions were recorded using a force displacement transducer (Chengdu TaiMeng).
After three equilibration, the aortic rings were contracted with phenylephrine (1 μM) to obtain a maximal response, and then a cumulative dose-response curve to acetylcholine (1 × 10 −9 -10 −4 M) and SNP (1 × 10 −9 -10 −4 M) was determined in thoracic aorta, respectively. In vitro, the aorta rings were pre-incubated with 50 mM glucose for 3.5 h to induce the endothelial vasodilation dysfunction. Nox4 inhibitor GKT137831 (10 −5 M) was incubated with aorta rings for 0.5 h.
Statistical analysis.
Data are presented as the mean ± SE. Significant differences between and within multiple groups were examined using analysis of variance for repeated measures, followed by Duncan's multiple-range test. Student's t test was used to detect significant differences between two groups. p < 0.05 was considered statistically significant.
Results

Argirein inhibited the apoptosis of RAECs under high glucose. The members of the B cell lymphoma
SCieNtifiC REpoRtS | (2018) 8:12620 | DOI:10.1038/s41598-018-30386-w intervention, the protein levels of BAX and Caspase-3 decreased compared with control ( Fig. 4a ). On the contrary, the expression of Bcl-2 protein significantly increased in response to argirein (Fig. 4a ).
Annexin V-FITC/PI double staining was further used to investigate anti-apoptotic role of argirein by flow cytometric assay. The results manifested that the Annexin V-FITC bound cell percentage of RAECs increased from 12.49% in control group to 32.50% in high glucose-treated group, while argirein intervention significantly inhibited the total apoptosis ratio to 13.46% (Fig. 4b,c ). In agarose electrophoresis, DNA fragments serves as an important symbol to reflect cell apoptosis by apoptotic DNA ladder kit 8 . As shown in Fig. 4d , high glucose treated group exhibited clear DNA ladder, which was dramatically improved by argirein intervention. Apoptotic cells labeled with TUNEL staining showed a cytoplasmic fluorescence which distinguished them with normal cells and necrotic cells. After TUNEL labeling, the TUNEL-positive cells were very low in normal control by fluorescence microscope. In contrast, high glucose-treated RAECs showed more TUNEL-positive cells to certify increased apoptotic ratio, which was significantly attenuated by the pretreatment with argirein ( Fig. 4e ,f). These assay above further consistently confirmed the anti-apoptotic role of argirein on in RAECs under high-glucose condition.
Argirein decreased O 2
−. production under high glucose. Given the anti-oxidative prosperity of argirein, the fluorescent spectrometry of a fluorescent probe dihydroethidium (DHE) was employed to detect intracellular O 2 −. production. RAECs treated with high glucose showed a strong red fluorescence produced from DHE oxidization by O 2 −. (Fig. 5a ). Argirein intervention apparently blocked the increase of fluorescent intensity in respond to high glucose (Fig. 5b) . By using the eletron spin resonance (ESR) spectrometry, we further determined the role of argirein on high glucose-induced the O 2 −. production in RAECs, Fig. 5c showed representative changes in superoxide dismutase (SOD)-inhibitable ESR spectrometric curve recorded by ESR spectrometer. The summarized data in Fig. 5d showed that high glucose significantly increased O 2 −. production dependent on NADPH oxidase in the RAECs, which was markedly attenuated by argirein intervention. Taken together, these assays illustrated that argirein indeed had an anti-oxidative prosperity through suppressing NADPH oxidase-dependent O 2 .production.
Nox4 mediated the anti-apoptotic role of argirein. In order to dive deeper into the molecular mechanisms underlying the role of argirein in O 2 .production, the possible involvement of Nox4 was examined. Here, we found that Nox4 protein dramatically increased in RAECs incubated with high glucose, which was inhibited by argirein ( Fig. 6a ). However, there was no significant difference in Nox1 or Nox2 protein expression after the treatment with argirein (not shown). To elucidate the role of Nox4 protein on apoptosis in RAECs, we next examined whether RAECs lacking Nox4 gene exhibited the apoptosis. Nox4 siRNA was transfected into RAECs and the apoptosis was observed, which efficacy of Nox4 siRNA transfection in RAECs was 64.1% (Fig. 6b) . The apparent inhibition of O 2 .production due to Nox4 siRNA transfection confirmed the transfection efficacy Nox4 siRNA ( Fig. 6c ), suggesting that O 2 .production during high glucose stimulation was mainly originated from Nox4 activation. As showed in Fig. 6d -g, Nox4 siRNA resulted in a significant decrease in the level of Bax and caspase-3 as well as the increase of Bcl-2 under high glucose stimulation.
ET-1 mediates Nox4-dependent oxidative stress through the combination with endothelin A receptor (ET A R) and/or endothelin A receptor (ET B R) in vitro 16 . As showed in Fig. 6h and i, the protein level of ET A R dramatically increased in RAECs incubated with high glucose, and argirein effectively refrained ET A R expression. Although ET B R was also upregulated by high glucose, there was no significant response to argirein medication (not shown). Furthermore, the pretreatment with ET A R antagonist BQ123 suppressed the protein expression of Nox4 in RAECs (Fig. 6h,j) , which convincingly proved that ET A R indeed mediated the regulation of argirein on Nox4 expression. Taken together, these results indicated that the deactivation of ET A R/Nox4 signal pathway contributed to the inhibition of apoptosis by argirein.
Argirein attenuated vascular dysfunction in T2DM rats. Following an injection of STZ in rats
with HFD, blood fasting blood glucose (FBG) was significantly elevated relative to control group (Fig. 7a) . Simultaneously, homeostasis model assessment of insulin resistance (HOMA-IR) calculated as FBG and serum insulin in T2DM rats significantly increased, compared to control rats (Fig. 7b ). Thus, a successful T2DM model was established in vivo study. The intervention with argirein in the last 3 weeks resulted in an obvious decrease in FBG and HOMA-IR, which suggested that argirein could attenuate metabolic disorders and systemic insulin resistance in T2DM rats. In addition, the number of TUNEL-positive endothelial cells in argirein-treated group was significantly decreased compared to that in the T2DM rats, which was in line with results in vitro (Fig. 7c ).
As shown in Fig. 7d , the immunohistochemical analysis revealed no significantly visible precipitation of Nox4 and BAX was observed in the endothelium of aorta in normal rats. However, the definite amount of these proteins could be noted in T2DM rats as indicated by the conspicuous brown granules. The intensified precipitation of Nox4 and BAX proteins was significantly diminished following argirein intervention.
Endothelial cell apoptosis contributes to endothelial function impairment resulting in vascular dysfunction T2DM 3 . Vascular response to acetylcholine and SNP (10 −9 -10 −4 M) was tested, which evoked endothelium-dependent and endothelium-independent vasodilatation in thoracic aorta, respectively (Fig. 7e,f) . The endothelium-dependent relaxant responses to acetylcholine were much lower than control rat, which were apparently enhanced in T2DM rat treated with argirein. In the contrast, endothelial-independent vasorelaxation to SNP had no significant difference among three groups showing vascular smooth muscle had the normal ability to relax. Ultimately, GKT137831, a new type of specific inhibitor of Nox4 was used to explore the regulation of Nox4 on vascular dysfunction 19 . Glucose (50 mM, 3.5 h) incubation with rat thoracic aortas significant impaired the aorta relaxation responding to acetylcholine 20 , suggested that the function of aortic rings was injured in vitro (Fig. 7g ). GKT137831 treatment showed an effective improvement in aorta relaxation, revealing that the inhibition of Nox4 could reverse endothelium-dependent relaxation suffered from hyperglycemia damage. Similarly, no significant differences on sodium nitroprusside (SNP)-induced relaxation were observed among the control group and high glucose group with or without GKT137831 (Fig. 7h ).
Discussion
In the present study, we provided novel evidences that ET-1/Nox4 signal-dependent O 2 −. generation was critical for suppressing the apoptosis of RAECs triggered by high glucose. Argirein, a derivative of rhein had an anti-apoptosis role through inhibiting the activation of ET-1/Nox4 signal-dependent O 2 −. generation in RAECs. Simultaneously, we demonstrated that T2DM-induced vascular dysfunction was alleviated by argirein intervention through inhibiting Nox4-associated endothelial apoptosis.
Endothelium dysfunction is the hallmark of these vascular complications of diabetes mellitus, and is considered to be the initiating event in atherosclerosis 2 . Apoptosis is the first-identified form of regulated cell death and is considered as the sole form of regulated cell death for decades 21 . Understanding endothelial apoptotic pathways that are altered in vascular complications of diabetes may enable a greater understanding of disease pathogenesis and foster the development of new therapies. Risk factors for cardiovascular diseases including hyperglycemia contributed to vascular endothelial cell dysfunction and apoptosis 9 , which was confirmed in RAECs treated with high glucose in current study. We repeatedly verified that argirein existed an anti-apoptotic role in RAECs as manifested with the normalization of BAX and Bcl-2 and Caspase-3 protein expressions, and the decrease of Annexin V-FITC bound cell percentage and the improvement of DNA ladder in agarose electrophoresis. At the first time, our study provided stronger evidences that argirein was potential in treating vascular complications of diabetes. The previous study from our group found that argirein inhibited hepatocyte apoptosis to blunt hepatosteatosis in diabetic rats 8 . Thus, the anti-apoptotic role of argirein is an underlying mechanism involved in the therapy targeting diabetic vascular complications. Risk factors for cardiovascular diseases include hyperglycemia and ROS, which collectively contributes to vascular endothelial cell dysfunction. ROS is important mediator of cell growth, adhesion, differentiation, migration, senescence, and apoptosis 22 . Here, we demonstrated that argirein indeed had a apparently anti-oxidative role in RAECs through inhibiting O 2 −. reduction by DHE staining and ESR assay. Argirein exhibited antioxidant activities with a prolonged t 1/2 compared with rhein, which was also found in diabetic hypogonadism, diabetic nephropathy and diabetic cardiomyopathy 5, 13, 23 . Rhein was an effective ingredient isolated from Chinese rhubarb (Rheum Officinale Baill.) and has been used alone or in a combined therapy 24 . It was reported that rhein protected vascular endothelial cells against oxidative injury through increasing the antioxidant including the SOD and glutathione peroxidase (GSH-PX) activity 25 . However, the solubility of rhein is poor, and its t 1/2 is not sufficiently long. L-arginine was converted by nitric oxide synthase (NOS) as a donor for NO, which caused sustained suppression of NADPH oxidase-dependent superoxide production in human endothelial cells by S-nitrosylation of p47phox 26 . The chemical modification by connecting a moiety of L-arginine was conducted to improve biological behaviors of argirein 4 . Therefore, the suppression of O 2 −. production was closely associated with its anti-apoptotic role in RAECs. ROS can trigger apoptosis either indirectly through damage to DNA, lipids, and proteins or directly by ROS-mediated activation of signaling molecules. Such proapoptotic signaling by ROS may occur through activation of MAP kinases, such as SAPK/JNK, ERK1/2, and p38 27 . Thus, it is possible that the inactivation of MAP kinases is responsible for anti-apoptosis of argirein.
The major source of ROS generated in the cardiovascular system is the NADPH oxidase, which activation has also been implicated in apoptosis 28 catalytic NADPH oxidase homologues, high expression of Nox4 appears to be a specific characteristic of vascular cells, although Nox2 expression also has been reported 29, 30 . In addition, Nox4 upregulation has been implicated in the development of cardiovascular pathologies 31 . Here, we found that Nox4 was responsive for ROS level in RAECs and anti-apoptosis of argirein. Interestingly, there was no significant difference in Nox2 and Nox1 protein expression after the treatment with argirein, which mechanisms still needed further study in future. Thus, Nox4-dependent ROS aggregation is the main cause of vascular endothelial cell apoptosis, the inhibition of which accounted for anti-apoptosis of argirein in RAECs.
ET-1 is a potent vasoconstrictor released mainly from endothelial cells and has been implicated in the development of coronary vascular pathophysiology by acting with ET A R and ET B R 32 . Hyperglycemia-induced production of ET-1 is a hallmark of endothelial dysfunction in diabetes 33 . ET-1 is able to activate NADPH oxidase in endothelial cells resulting in the disturbance of vascular redox balance 11, 12 . Our current study found both ET A R and ET B R level were increased in respond to high glucose stimulation. However, argirein could only attenuate ET A R protein rather than ET B R, which was possibly because of the different role of ET A R and ET B R in vascular injury. ET-1 acting on the ET A R, promoted intimal lesion formation following vascular injury 34, 35 . ET B R mediated NO release and ET-1 clearance in endothelial cells, may moderate lesion formation 36 .Thus, this protective effect of argirein is not mediated by those ET B R expressed by endothelial cells. The selective ET A R antagonist BQ123 completely prevented high glucose induced elevation of Nox4 expression, which demonstrated that ET-1 induced Nox4 activity through activating ET A R and therefore disrupted cell apoptosis induced by high glucose. Thus, ET A R /Nox4 constructed a signal pathway which was responsible to anti-apoptotic role of argirein in RAECs. Consistently, our previous study showed that ET A R significantly enhanced ROS generation via a NADPH oxidase-dependent pathway implicated in the apoptosis of HK-2 cells 16 .
In vivo study, T2DM rats produced by HFD/low STZ impaired endothelium-dependent relaxation in isolated aorta, providing a well-characterized model of endothelial dysfunction. We found that argirein inhibited systemic insulin resistance and decreased the blood glucose in T2DM rats. The relaxation of aortic rings responding to an endothelium-dependent vasodilator such as acetylcholine but not to an endothelium-independent vasodilator such as SNP was impaired in T2DM rats, whereas the impairment could be prevented by argirein medication. In addition, the impaired endothelium-dependent vasodilation has been established in aorta rings incubated with high glucose condition. Selective Nox4 inhibitor GKT137831 almost completely restored endothelium-dependent relaxation, confirming that argirein mediated vascular relaxation via inhibiting Nox4 activity. Consistent with the results in RACEs, the results from immunohistochemistry suggested that Nox4 and BAX were activated in the aorta of rats fed with HFD/low STZ. Argirein significantly deceased the levels of Nox4 and BAX in the endothelium of aorta, which further confirmed that argirein ameliorated endothelial apoptosis through suppressing Nox4, consequently resulting in relieving the vasodilatation dysfunction. In our recent study, we indeed found that the intervention of argirein was useful to normalize insulin-mediated endothelial dysfunction via recovering insulin sensitivity 37 . Here, we didn't analysis the insulin sensitivity in endothelial cell, but we demonstrated that argirein ameliorated systemic insulin sensitivity in the diabetic rats. Actually, it was well-known that insulin resistance is accompanied by the increases in apoptosis in different cells which is associated with diabetic complication 38, 39 . Our previous study also demonstrated that argirein blunted hepatosteatosis through normalizing apoptosis and insulin resistance in the diabetic liver 8 . Thus, it is suggested that the improvement of vascular dysfunction by argirein owed to increasing the insulin sensitivity and inhibiting endothelial cell apoptosis.
In conclusion, we demonstrated that high glucose leaded to the production of ET-1/Nox4 signal-dependent O 2 − , consequently triggering the apoptosis in RAECs, which was involved in the pathology of diabetic vascular dysfunction. Argirein can improve vascular function through inhibiting endothelial apoptosis, which was associated with the reduction of ET-1/Nox4 signal-dependent O 2 − production. These findings suggest that argirein is a potential therapeutic drug in alleviating vascular complications in T2DM.
